세계의 정형외과 기기 시장 규모는 2023년에 440억 9,000만 달러, 2030년 577억 9,000만 달러에 달하며, 2024-2030년의 예측 기간에 CAGR로 4.78%의 성장이 전망됩니다. 시장은 65세 이상 인구의 증가, 골관절염 및 골다공증 등 골질환의 증가, 직업성 및 비직업성 외상의 증가, 의료 기술의 기술적 발전 등의 요인에 의해 매출이 증가할 전망이며, 예측 기간(2024-2030년)에 시장 매출의 성장이 전망됩니다.
정형외과 기기 시장 역학
정형외과 기기 시장의 주목할 만한 촉진요인 중 하나는 세계의 노년 인구 증가입니다. World Population Prospects(2019)의 리포트에 따르면 세계 인구 11명 중 1명이 65세 이상이며, 2050년에는 세계 인구 6명 중 1명이 65세 이상이 될 것으로 예상됩니다. 될 것이라고 합니다. 또한 북미와 유럽 등의 지역에서는 2050년까지 4명 중 1명이 65세 이상이 될 것으로 예측됩니다. 노인 인구 증가는 또한 골관절염과 같은 다양한 유형의 골질환으로의 길을 열어 수술, 임플란트 및 장기적인 보조를 위해 수술, 임플란트 및지지 요법을 필요로하는 골관절염과 같은 다양한 유형의 골질환으로의 길을 열어줍니다. 무릎 관절염과 골관절염의 가장 강력한 발생 요인이며, 임플란트가 가장 선호되는 기기입니다.
정형외과 기기 시장의 성장을 이끄는 또 다른 주요 요인은 안전하고 생체 적합성이 높은 임플란트 제조의 지속적인 기술 발전입니다. 예를 들어 2022년 5월 Orthofix US Inc.는 복잡한 관절 수술 중 초음파 관절 재치환 시스템에 사용되는 OSCAR PRO를 미국 및 유럽 시장에 출시했습니다. 이러한 제품 개발 활동은 연구개발 영역이 활발하다는 것을 보여주며, 그 결과 개선된 제품이 시장에 출시되어 제품 보급에 기여하고 시장 성장에 기여하고 있습니다.
그러나 대체 요법의 가용성과 정형외과 기기(특히 임플란트)와 관련된 합병증은 정형외과 기기 시장의 성장을 저해하는 요인으로 작용할 수 있습니다.
정형외과 장비 시장은 COVID-19 감염 사슬을 끊기 위해 필요한 조치로 봉쇄 조치가 시행되면서 단기적인 후퇴가 보고되었으며, COVID-19 팬데믹으로 인해 의료 서비스 및 의료 절차의 대대적인 재편이 이루어졌습니다. 많은 국가에서 COVID-19 위기 동안 업무 흐름을 간소화하기 위해 응급의료의 필요성에 따라 의료 절차를 분리하고 선택적으로 간주되는 다양한 의료 절차가 중단되었습니다. 예를 들어 Organization for Cooperation and Development(2023)에 따르면 2020년 3월 이탈리아, 아일랜드, 노르웨이 등 대부분의 국가에서 고관절 및 무릎 인공관절 수술 건수가 급격히 감소했습니다. 대부분의 국가는 COVID-19 대응에 집중하기 위해 긴급한 경우에만 외과수술을 채택했습니다. 그러나 의료 부문을 포함한 산업 전반의 활동이 재개되면서 정형외과 장비 시장은 호황을 누리고 있습니다.
정형외과 기기 시장 부문별 분석
정형외과 기기 시장의 용도 중 척추용 정형외과 기기 카테고리는 예측 기간(2024-2030년) 동안 정형외과 기기 시장에서 큰 매출 성장을 기록할 것으로 예상됩니다. National Spinal Cord Injury Statistical Centre(2023)에 따르면 직업적 외상, 과도한 사용으로 인한 외상, 낙상, 싸움으로 인한 상처, 스포츠 선수의 척수 손상 등 다양한 이유로 척수 손상 사례가 증가하고 있기 때문인 것으로 추정된다, 2019년 전 세계에서 296만 6,000명이 척수 손상으로 생활하고 있으며, 매년 전 세계에서 1,7,900명이 새로 발병하고 있습니다. 이는 사람들에게 더 많은 지원 메커니즘과 효율적인 수술에 대한 필요성을 가져오고, 정형외과 산업이 더 안전하고 생체 적합성이 높은 임플란트를 평생 동안 사람들에게 제공하도록 장려합니다.
세계의 정형외과 기기 시장에 대해 조사분석했으며, 시장 규모와 예측, 촉진요인과 과제, 기업과 제품 개요 등을 제공하고 있습니다.
Orthopedic Device Market Type By Product (Implants, Supports, And Others), By Application (Knee Orthopedic Devices, Hip Orthopedic Devices, Wrist Orthopedic Devices, Shoulder Orthopedic Devices, Spine Orthopedic Devices, Ankle Orthopedic Devices, And Others ), By End-User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centres, And Others), by geography is estimated to register growth at a remarkable CAGR forecast during 2024-2030 owing to upsurge in prevalence of ageing population and rise in the cases of bone disorders.
The global orthopedic devices market was valued at USD 44.09 billion in 2023, growing at a CAGR of 4.78% during the forecast period from 2024 to 2030 to reach USD 57.79 billion by 2030. The orthopedic devices market is slated to witness increasing revenue owing to factors such as a growing population of people above the age of 65, a rise in the cases of bone disorders such as osteoarthritis and osteoporosis among others, increasing cases of occupational injuries and non-occupational injuries along with latest technological developments in healthcare technology are further expected to result in the appreciable revenue growth in the orthopedic devices market during the forecast period (2024-2030).
Orthopedic Devices Market Dynamics:
One of the noteworthy drivers of the orthopedic devices market is the rising population of old age people globally. As per the reports from World Population Prospects (2019), one in eleven people in the world are above the age of 65 and their proportion shall increase to one in six people in the world to be aged above 65 years, by the year 2050. The same source also stated that in regions like North America and Europe, it is expected that one in four people shall be above the age of 65 years by the year 2050. The increase in the geriatric population, also paves the way for various types of bone disorders like osteoarthritis, requiring surgical procedures, implants, and support therapies for long-term assistance. According to the Organization for Cooperation and Development (2023), age is the strongest factor for the occurrence of Knee and Hip Osteoarthritis, where implants are the most preferred devices among others.
Another key factor responsible for the growth of the orthopedic devices market is the continuous technological advancements in manufacturing safe and biocompatible implants. For instance, in May 2022, Orthofix US Inc. launched OSCAR PRO for use in ultrasonic arthroplasty revision systems during complex joint surgeries, in the U.S and European markets. Such product development activities indicate an active research and development domain resulting in the launch of improved products in the market, contributing to product uptake and ultimately resulting in market growth.
However, the availability of alternative therapies and complications associated with orthopedic devices, specifically implants, may act as restraining factors to the orthopedic devices market growth.
The orthopedic devices market reported a short period of setback due to the implementation of lockdown as necessary measures to break the chain of the COVID-19 infection transmission. The COVID-19 pandemic resulted in the massive reorganization of healthcare services and the carrying out of medical procedures. Many countries segregated medical procedures based on the need for urgent medical care to streamline the workflow during the COVID-19 crisis and saw various medical procedures considered elective being suspended. For instance, in March 2020, according to the Organization for Cooperation and Development (2023), most countries like Italy, Ireland, and Norway showed a sharp decline in the number of hip and knee replacement surgeries. Most countries adopted surgical procedures only in cases of immediate urgency to focus more on handling the COVID-19 situation. However, with the resumption of activities across industries including the healthcare sector, it has been uplifting the orthopedic devices market.
Orthopedic Devices Market Segment Analysis:
Orthopedic devices Market Type by Product (Implants, Supports, and others), Application (Knee Orthopedic Devices, Hip Orthopedic Devices, Wrist Orthopedic Devices, Shoulder Orthopedic Devices, Spine Orthopedic Devices, Ankle Orthopedic Devices, and Others), End-User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centres and others), Geography (North-America, Europe, Asia-Pacific, Rest of the World)
Based on the application segment of the orthopedic devices market the spinal orthopedic devices category is projected to register significant growth in revenue in the orthopedic devices market during the forecast period (2024-2030). This can be ascribed to the rising cases of spinal cord injuries for various reasons such as occupational work, overuse injuries, falls, wounds from fights, spinal injuries to athletes, etc. According to the National Spinal Cord Injury Statistical Centre (2023) in the year 2019, 2,96,000 people were living with spinal cord injuries globally, with 17,900 new cases happening every year around the world. This brings the need for more assistance support mechanisms and efficient surgical procedures for people, which drives orthopedic industries to deliver safer, biocompatible implants for people on a lifetime basis.
Therefore, considering the growing demand for this product type, numerous new products are being launched in the market. For instance, in October 2020, Stryker Corporation introduced Niagra Lateral Access System for spinal injuries and deformities, after the completion of successful 600 surgeries. The implant is widely compatible with patients, allowing fewer chances of contamination and side effects, with a biocompatible titanium. Therefore, considering the advantages associated with spinal reconstruction devices and their growing popularity among end-users, this product segment is expected to generate considerable revenue thereby pushing the overall growth of the global orthopedic devices market during the forecast period.
North America is expected to dominate the overall Orthopedic Devices Market:
Among all the regions, North America is expected to lead in revenue generation in the global orthopedic devices market. This can be ascribed to the growing population of old-aged people in the region. For instance, according to the U.S. Census Bureau (2023), the old age population observed an increase of 34.2%, from 40.3 million U.S. residents aged 65 years in the year 2010 to 54.1 million or older in the year 2019.
One of the prominent factors supporting the growth of the North America orthopedic devices market is the rising prevalence of bone disorders like osteoarthritis, osteoporosis, etc. For example, as per the CDC report (2023), more than 32.5 million people are affected by Osteoarthritis which is one of the most common forms of joint disorders in the United States. Along with the growing aged population, the risk of bone disorders also increases. For instance, according to the Osteoarthritis Action Alliance (2023), in the year 2019, 43% of people aged above 65 years and 88% of people aged above 45 years were diagnosed with Osteoarthritis. The source further stated that more than 60% of people affected were women. Considering the rising number of bone disorders in the country, numerous products are receiving regulatory approvals thus paving the way for their market launch. For instance, in May 2022, the U.S. Food and Drug Administration (FDA) approved the AccelStim Bone growth Stimulator, manufactured by Orthofix US LLC, which can be used in cases of bone fractures. Also, In September 2020, Stryker Corporation launched its titanium-made AxSOS Ankle Fusion System for the tibiotalar joint with updated screw offerings.
Therefore, the presence of a large patient base coupled with increasing cases of bone disorders drives manufacturers to launch new products, which is expected to drive the growth of the orthopedic devices market in the United States during the forecast period.
In addition to the rising old age population and cases of bone disorders, there has been an increase in the number of occupational injuries and non-occupational injuries in the United States. For example, according to the U.S Bureau of Labor Statistics (2023), an incidence rate of 25.4% of occupational injuries was observed of which 24% of injuries consisted of traumatic injuries in the year 2020. The source also stated that there were about 53,000 cases of injuries to the bone, cartilage, and tendons along with sprains, strains, and muscle tears, resulting from non-occupational reasons such as violence, abuse, and fights requiring implants and other assistance mechanisms. Therefore, such reasons coupled with a large patient pool having bone disorders and occupational injuries shall further drive the demand for orthopedic devices in the United States during the forecast period.
Orthopedic Devices Market Key Players:
Some of the key market players operating in the orthopedic devices market include Stryker Corporation, Zimmer Biomet, Johnson and Johnson, Enovis, Smith & Nephew PLC, Medtronic PLC, Boston Scientific Corporation, NuVasive Inc., Globus Medical Inc., ConMed Corporation, Bioventus, Orthofix, Colson Medical LLC, Exactech Inc., Medacta International, Surgalign Holdings, Paragon 28 Inc, Orthofix, Arthrex Inc., Seimens, Bosch Global, and others.
Recent Developmental Activities in the Orthopedic Devices Market:
In May 2022, Orthofix US LLC got approval from the FDA for its orthopedic device AccelStim Bone Growth Stimulator in Texas, USA, which can be used in cases of bone fractures.
In March 2022, Stryker launched the Insignia Hip stem, used for total hip stem arthroplasty and hemi-arthroplasty processes, at the American Academy of Orthopedic Surgeons Annual Meeting.
In June 2022, Medtronic received FDA clearance for UNiD rods, screws, and fusion devices that uses Artificial Intelligence Technology for treating spinal injuries.
Key Takeaways from the Orthopedic Devices Market Report Study
Target Audience who can be benefited from this Orthopedic Devices Market Report Study
Frequently Asked Questions for Orthopedic Devices Market:
Orthopedic devices can be defined as any device, physical support, or implant assisting the human body, mostly in the skeletal system to restore damaged bones, joints, ligaments, and other neighboring structures to recover primary functional locomotive abilities.
The global orthopedic devices market was valued at USD 44.09 billion in 2023, growing at a CAGR of 4.78% during the forecast period from 2024 to 2030 to reach USD 57.79 billion by 2030.
The orthopedic device market is expected to grow significantly owing to factors such as the growing prevalence of bone diseases such as osteoarthritis, osteoporosis, etc. The global rise in the old age population also will lead to an increase in the number of assistance and support devices in the future. Increasing cases of occupational injuries and road accidents are further expected to result in appreciable revenue growth in the orthopedic device market during the forecast period (2024-2030).
Some of the key market players operating in the orthopedic devices market include Stryker Corporation, Zimmer Biomet, Johnson and Johnson, Enovis, Smith & Nephew PLC, Medtronic PLC, Boston Scientific Corporation, NuVasive Inc., Globus Medical Inc., ConMed Corporation, Bioventus, Orthofix, Colson Medical LLC, Exactech Inc., Medacta International, Surgalign Holdings, Paragon 28 Inc, Orthofix, Arthrex Inc., Integra Lifesciences, Bosch Global, and others.
North America is expected to dominate the overall Orthopedic device market during the forecast period, 2024 to 2030. This can be ascribed to the presence of a large old age population in the North American region. Increasing cases of bone disorders like osteoarthritis and osteoporosis and weak skeletal system also do play a major role in driving the orthopedic device market in the region. In addition, it is a highly potent market in terms of product development and launches, and the presence of key market players also driving the market growth.